Company completes two year milestone for phase I/II trial for Autism
MELBOURNE: A company has completed its two year milestone for phase I/II trial for Autism.
MELBOURNE: A company has completed its two year milestone for phase I/II trial for Autism.
FEATURED
Locally developed disability-inclusive banking training goes global
Tech firm launches AI workforce platform for disability providers
NextSense centre for accessibility innovation wins Good Design Award
Virgin Australia apologises after breaking girl’s $33,000 wheelchair
‘Forever home’ project now offering hope for most vulnerable
Eating disorder experts now warn against online wellness economy